CollPlant Biotechnologies CLGN
NASDAQ CLGN
$3.42 -0.15 (-4.20%)
At close: Oct 2, 2026 · 4:00 PM EDT

CollPlant Biotechnologies (CLGN) Return on Assets [ROA] (2018 - 2025)

Updated

CollPlant Biotechnologies (CLGN) recorded Return on Assets [ROA] of -42.61% in the quarter ended Dec 31, 2025, down 2.16 percentage points from -40.46% a year earlier but up 49.71 percentage points from the prior quarter.

Analysis

CollPlant Biotechnologies (CLGN) Return on Assets [ROA] (2018 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, CollPlant Biotechnologies reported Return on Assets [ROA] of -77.90%, down 15.03 percentage points from the prior year.

  • Annual Return on Assets [ROA] has a five-year change of -131.39 percentage points (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Return on Assets [ROA] came in at -62.87% in the year ended Dec 31, 2024 (-43.34 pp), -19.53% in the year ended Dec 31, 2023 (+18.51 pp), -38.04% in the year ended Dec 31, 2022 (-38.95 pp) and 0.92% in the year ended Dec 31, 2021 (-52.57 pp).
  • Quarterly Return on Assets [ROA] has ranged from -92.32% in the quarter ended Sep 30, 2025 to 63.47% in the quarter ended Mar 31, 2021 over the past five years.
  • On a year-over-year basis, Return on Assets [ROA] rose in three of the last six quarters, with an average year-over-year change of -8.90 percentage points.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 48.35 percentage points in the quarter ended Mar 31, 2024, against a drop of 162.90 percentage points in the quarter ended Sep 30, 2021 at the low end.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 CollPlant Biotechnologies 4.38 Mn -25.06 Mn -456,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -42.61%
Sep 30, 2025 -92.32%
Dec 31, 2024 -40.46%
Sep 30, 2024 -1.69%
Jun 30, 2024 -1.64%
Mar 31, 2024 2.50%
Dec 31, 2023 0.91%
Sep 30, 2023 -17.67%
Jun 30, 2023 -18.08%
Mar 31, 2023 -45.84%
Dec 31, 2022 -42.67%
Sep 30, 2022 -19.96%
Jun 30, 2022 -15.29%
Mar 31, 2022 -11.84%
Dec 31, 2021 0.61%
Sep 30, 2021 23.44%
Jun 30, 2021 29.48%
Mar 31, 2021 63.47%
Dec 31, 2020 109.40%
Sep 30, 2020 186.34%
API Access

CollPlant Biotechnologies Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CLGN&period=max&api_key=YOUR_API_KEY